Heidi Ling is an assistant professor in the School of Biomedical Sciences, the University of Hong Kong (HKU). She obtained her BSc and PhD at HKU and did her postdoctoral training at Imperial College London. She started her own group in 2019 and her primary research interests lies in understanding the mechanisms behind immune dysregulation in various chronic inflammatory diseases, particularly those that contribute to inflammation-driven cancers.

Ling’s research focuses on the metabolic reprogramming of immune cells in chronic inflammatory diseases. Her laboratory employs emerging technologies from the field of immunometabolism to assess the effects of sustained inflammation on exhausted T cell differentiation as well as the implications of tumor-immune coevolution on the efficacy of cancer immunotherapy.